Related Experiment Video
Updated: Jul 18, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta
B M Forman1, I Tzameli, H S Choi
1The City of Hope National Medical Center, Duarte, California 91010, USA. bforman@gte.net
Abstract:
The orphan receptor CAR-beta binds DNA as a heterodimer with the retinoid-X receptor and activates gene transcription in a constitutive manner. Here we show that, in contrast to the classical nuclear receptors, the constitutive activity of CAR-beta results from a ligand-independent recruitment of transcriptional co-activators. While searching for potential ligands of CAR-beta, we found that the steroids androstanol and androstenol inhibit the constitutive activity of CAR-beta. This effect is stereospecific: only 3alpha-hydroxy, 5alpha-reduced androstanes are active. These androstanes do not interfere with heterodimerization or DNA binding of CAR-beta; instead, they promote co-activator release from the ligand-binding domain. These androstane ligands are examples of naturally occurring inverse agonists that reverse transcriptional activation by nuclear receptors. CAR-beta (constitutive androstane receptor-beta), therefore, defines an unanticipated steroidal signalling pathway that functions in a manner opposite to that of the conventional nuclear receptor pathways.
Insights
Constitutive Androstane Receptor-beta (CAR-beta) activity is inhibited by specific androstane steroids. These steroids act as inverse agonists, reversing CAR-beta
Area of Science:
- Molecular Endocrinology
- Steroid Signaling Pathways
- Nuclear Receptor Research
Background:
- The orphan receptor CAR-beta (constitutive androstane receptor-beta) forms heterodimers with the retinoid-X receptor.
- CAR-beta constitutively activates gene transcription independently of ligand binding.
- Classical nuclear receptors typically require ligand binding for transcriptional activation.
Purpose of the Study:
- To investigate the mechanism behind CAR-beta's constitutive activity.
- To identify potential ligands that modulate CAR-beta activity.
- To characterize the nature of identified ligands and their mechanism of action.
Main Methods:
- Screening for potential ligands of CAR-beta.
- Assessing the effect of identified steroids on CAR-beta's constitutive transcriptional activity.
- Evaluating the stereospecificity of the steroid interaction.
- Analyzing the impact of steroids on CAR-beta heterodimerization, DNA binding, and co-activator recruitment/release.
Main Results:
- Androstanol and androstenol were identified as inhibitors of CAR-beta's constitutive activity.
- The inhibitory effect was stereospecific, requiring a 3alpha-hydroxy, 5alpha-reduced androstane structure.
- These androstanes do not affect heterodimerization or DNA binding but promote co-activator release from CAR-beta.
Conclusions:
- CAR-beta functions via ligand-independent co-activator recruitment.
- Specific androstanes act as naturally occurring inverse agonists for CAR-beta.
- This defines a novel steroidal signaling pathway opposing conventional nuclear receptor mechanisms.
More Related Videos
Related Concept Videos
Intracellular Hormone Receptors
Internal Receptors
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...

